12th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology

描述（由申请人提供）：美国心脏协会的动脉硬化、血栓形成和血管生物学（ATVB）理事会每年举行春季会议。ATVB 2010是该系列的第11次会议，将于2010年4月7日至10日在旧金山弗朗西斯科举行。ATVB会议的规模随着时间的推移而增加，ATVB 2010有超过1000名注册者，到会议举行时将超过1100名参与者。ATVB会议的总体目标是汇集从事心血管疾病基础，转化和临床方面工作的初级和高级科学家，以便科学交流和快速传播与我们对心血管系统生理学和病理生理学的理解相关的新发现。会议的具体目标是：1）促进在心血管疾病的各个重要领域工作的研究人员之间的科学信息和实验策略的交流; 2）识别和传播有关新技术的信息，这些新技术可以促进所有领域的研究; 3）促进基础科学发现转化为转化/临床前研究，并最终转化为临床应用; 4）鼓励相关领域的研究人员熟悉并促进科学合作; 5）为学生和研究员提供一个向知情观众展示数据的场所，以鼓励他们在该领域的发展和保留。会议旨在通过提供一个论坛来展示约500份个人海报或口头介绍来实现这些目标。早期职业调查人员的整合和教育进入这些讨论，我们的第五个目标，是该计划的一个特别重要的组成部分。会议的规模很小，足以让学生和研究员积极参加海报和口头会议，并相互交流，并与著名的国家和国际科学家不仅从他们的研究领域，而且从动脉硬化，血栓形成和血管生物学的各个方面。这项申请特别要求提供资金，以便通过提供旅行奖，努力让年轻调查员参与和融入外地工作。一个成功的制度是鼓励年轻的研究人员申请这些奖项，根据科学价值判断最高的申请，并在会议上承认获奖者。成功续发现有拨款所提供的资金将用于支持2011年至2016年每年ATVB会议的旅行奖，并将有助于确保ATVB会议将继续为早期研究人员提供一个平台，使其成为科学界的参与者和贡献者。 公共卫生相关性：这项更新申请寻求对青年研究人员参加美国心脏协会动脉炎、血栓形成和血管生物学年会的旅行奖的支持。ATVB会议为早期研究人员提供了独特的机会，让他们与同行见面，展示他们的工作，并与不同学科的高级同事互动，这些学科对心血管疾病感兴趣，并将其作为一个统一的主题。

DESCRIPTION (provided by applicant): The Council of Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) of the American Heart Association holds an annual Spring meeting. ATVB 2010 is the 11th meeting in the series and will be held in San Francisco, April 7-10, 2010. The size of the ATVB meeting has increased over time and ATVB2010 has over 1000 registrants and should exceed 1100 participants by the time of the meeting. The overall goal of the ATVB meetings is bring together junior and senior scientists working on basic, translational and clinical aspects of cardiovascular disease for the purpose of scientific interchange and rapid dissemination of new discoveries that are relevant to our understanding of the physiology and pathophysiology of the cardiovascular system. The specific aims of the conference are: 1) to promote the exchange of scientific information and experimental strategies among investigators working in diverse areas of great importance in cardiovascular disease; 2) to identify and disseminate information about novel technologies that can advance research across all areas; 3) enhance the transfer of basic science findings into translational/preclinical studies and ultimately to clinical applications; 4) to encourage investigators in related fields to become acquainted and to promote scientific collaborations; and 5) to provide a venue for students and fellows to present data to an informed audience with an eye toward encouraging their development and retention in the field. The meeting is designed to meet these aims by providing a forum for presentation of about 500 individual poster or oral presentations. Integration and education of early career investigators into these discussions, our fifth aim, is a particularly important part of the program. The size of the meeting is small enough to permit students and fellows to actively participate in poster and oral sessions and to interact with one another and with well known national and international scientists not only from their area of research but also from the diverse aspects of arteriosclerosis, thrombosis and vascular biology. This application specifically requests funds for its effort to engage and integrate young investigators into the field through its provision of Travel Awards. A successful system is in place to encourage young investigators to apply for these awards, to judge the top applications based on scientific merit, and to recognize the awardees at the meeting. The funds provided by a successful renewal of this existing grant would support the Travel Awards to each of the annual ATVB meetings from 2011 through 2016 and will help to assure that the ATVB meeting will continue to provide a platform for early stage investigators to become engaged and contributing members of the scientific community. PUBLIC HEALTH RELEVANCE: This renewal application seeks support for Travel Awards for Young Investigators to attend the annual meetings of the Arteriosclerosis, Thrombosis and Vascular Biology Meetings of the American Heart Association. The ATVB meetings provide unique opportunities for early stage investigators to meet peers, present their work, and interact with senior colleagues across distinct disciplines that have an interest in cardiovascular disease as a unifying theme.